Lentiviral-Mediated Gene Therapy in Fanconi Anemia-A Mice Reveals Long-Term Engraftment and Continuous Turnover of Corrected HSCs

Publisher： Bentham Science Publishers

E-ISSN： 1875-5631|15|6|550-562

ISSN： 1566-5232

Source： Current Gene Therapy, Vol.15, Iss.6, 2015-12, pp. : 550-562

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anchored Lentiviral Vector Episomes for Stem Cell Gene Therapy in Fanconi Anemia

By  

Current Gene Therapy, Vol. 16, Iss. 5, 2017-02 ,pp. : 329-337

Bentham Science Publishers

Access to resources Recommend Favorite

Lentiviral-mediated gene transfer – a patent review

By Picanço-Castro Virginia   Fontes Aparecida Maria   Russo-Carbolante Elisa Maria de Sousa   Covas Dimas Tadeu  

Expert Opinion on Therapeutic Patents, Vol. 18, Iss. 5, 2008-05 ,pp. : 525-539

Informa Healthcare

Access to resources Recommend Favorite

A Possible Approach for Stem Cell Gene Therapy of Fanconi Anemia

By  

Current Gene Therapy, Vol. 9, Iss. 1, 2009-02 ,pp. : 26-32

Bentham Science Publishers

Access to resources Recommend Favorite

Long-term results of ADA gene therapy

By  

Inpharma, Vol. 1, Iss. 1388, 2003-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite

Gene Therapy in Fanconi Anemia: A Matter of Time, Safety and Gene Transfer Tool Efficiency

By  

Current Gene Therapy, Vol. 16, Iss. 5, 2017-02 ,pp. : 297-308

Bentham Science Publishers

Access to resources Recommend Favorite